Tawel, H.M. , Hasen, Y.M.A. and Miles, A. 2022. Cancer Testis Antigen (CTA) T21, as a Potential Diagnostic, Prognostic, and Immune-Therapeutic Targets for Malignant Tumours. Journal of Medical Sciences. 17, 1 (Jan. 2022), 1–7. DOI:https://doi.org/10.51984/joms.v17i1.1892.